“…C rystalline nanomaterials can be conjugated with a variety of biomolecules, including peptides, proteins (e.g., antibodies and enzymes), nucleic acids (e.g., aptamers), and lipids, for enhancing their biocompatibility and in vivo circulation, as well as for enabling cell recognition and intracellular delivery [1][2][3][4][5] . This approach is becoming increasingly prominent for diagnosis and treatment of cancer, anemia, diabetes, and Alzheimer's disease via nano-enabled biosensors, bioimaging, and drug delivery [6][7][8] . Significant attention has focused on modulating the interaction between crystalline nanomaterials and biomolecules through manipulating the morphology, particle size, and surface functionalities of nanocrystals [9][10][11][12] , whereas exposed crystal facets, one of the most intrinsic properties of crystalline nanomaterials, remain largely unexplored.…”